MARKET RADAR
SENSEX     NIFTY      Refresh
You are here : MONEYCONTROL > MARKETS > SHARE PRICE > PHARMACEUTICALS > COMPANY INFO - GLENMARK PHARMA

Glenmark Pharma

BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
May 17, 17:00
572.10
-5.20 (-0.90%)
VOLUME 34,944
AVERAGE VOLUME
5-Day 59,587
10-Day 77,233
30-Day 78,334
VOLUME SHOCKER
5-Day 59,587
10-Day 77,233
30-Day 78,334
Prev. Close
577.30
Open Price
578.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
572.10 (5)
Today’s Low/High 561.55 580.00
52 Wk Low/High 332.25 580.00
LIVE
NSE
May 17, 17:00
574.85
-2.30 (-0.40%)
VOLUME 924,598
AVERAGE VOLUME
5-Day 706,745
10-Day 742,189
30-Day 502,517
VOLUME SHOCKER
5-Day 706,745
10-Day 742,189
30-Day 502,517
Prev. Close
577.15
Open Price
578.90
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
574.85 (36)
Today’s Low/High 562.65 579.95
52 Wk Low/High 307.35 579.95
Action in Glenmark Pharma
MARKET CAP (Rs Cr)
15,497.99
*P/E
40.15
*BOOK VALUE (Rs)
80.69
DIV (%)
200.00%
Market Lot
1
INDUSTRY P/E
28.46
*EPS (TTM)
14.25
*P/C
37.69
*PRICE/BOOK
7.09
DIV YIELD.(%)
0.35%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
86.44 new
DELIVERY AVERAGES
3-Day 77.68%
5-Day 70.86%
8-Day 64.88%
* Based on standalone numbers
Track Glenmark on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL
Would you bet on Glenmark today?
Test your strategy with virtual money on Moneybhai
Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 350.00 578.00  
High Price 358.60 580.00  
Low Price 338.50 561.55  
Last Price 341.15 572.10 67.70
Volume 138,233 34,944 -74.72
Simple Moving Averages
Days BSE NSE
30 505.66 506.13
50 499.29 499.44
150 481.15 481.31
200 464.51 464.68

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Glenmark

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
  (Mar '13)
Quarterly
(Mar '13)
Yearly
Net Sales 485.21 1949.30
Other Income 26.58 116.25
PBDIT 84.72 448.69
Net Profit 84.92 386.11

Annual Report

Download in PDF format 2012 |2011 |2010
Balance Sheet
(Mar '13)
(In Rs Cr)
Total Share Capital 27.05
Net Worth 2185.71
Total Debt 476.44
Net Block 227.13
Investments 1083.27
Net Current Assets 1270.40
Total Assets 2662.15
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 965.30 -0.33 997.95 569.00 99,964.73
Lupin 804.25 -0.33 810.80 519.00 36,001.21
Dr Reddys Labs 2077.65 -1.80 2150.90 1555.00 35,286.08
Cipla 424.65 0.57 435.00 305.00 34,096.06
Ranbaxy Labs 471.45 -0.77 578.30 370.50 19,947.10
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Mar' 13Dec' 12Sep' 12Jun' 12
Promoter48.3148.3248.3348.26
FII32.4033.2833.1233.46
DII8.126.736.735.44
Others11.1711.6711.8212.84
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road,
City
Mumbai
State
Maharashtra
Pin Code
400026
Tel. No.
022-40189999 022-40189879
Fax No.
022-40189986
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Plot No.17-24, Vittalrao Nagar, Madhapur
City
Hyderabad - 500081
State
Andhra Pradesh
Tel. No.
040-23420815, 23420816, 23420817, 23420818
Fax No.
040-23420814
MANAGEMENT
Name
Designation
Glenn Saldanha
Chairman & Managing Director
Cherylann Pinto
Executive Director
Rajesh V Desai
Executive Director & CFO
B E Saldanha
Non Executive Director
D R Mehta
Non Executive Director
Message Board & Community
Quick Links for Glenmark Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.